Development of novel therapeutic strategies to overcome resistance to tyrosine-kinase and bcl-2 inhibitors in FLT3-ITD+ Acute Myeloid Leukemia cells.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma